The rise of GLP-1s has made treat­ing obe­si­ty one of the largest mar­ket op­por­tu­ni­ties in his­to­ry. It al­so has re­in­forced a detri­men­tal re­la­tion­ship be­tween ...

New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss ...

The latter has made little difference: the popularity of Ozempic and other GLP-1 receptor agonists ... due to a surge in “off-label” prescriptions for weight loss. An “Ozempic crackdown ...

With obesity rates tripling over the past 60 years, GLP-1 medications dominated the conversation in 2024 as an effective solution for this pervasive issue. But are they a one-shot deal?

People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The suggested method is based on the amount of weight a person wants or needs to ...

will share insights into the mechanisms underlying the ability of these drugs to suppress feeding and reduce body weight, as well as consider emerging pharmacological approaches to treating obesity ...

Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...

Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...

Results of Omada Health's latest analysis suggest that upon discontinuing GLP-1s, it is possible to maintain the weight loss by implementing lifestyle modification strategies that include diet, ...